发布日期：2008年6月

摘要

OTC Healthcare in Canada market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.

目录及图表

Why buy this report

• Get insight into trends in market performance
• Pinpoint growth sectors and identify factors driving change
• Identify market and brand leaders and understand the competitive environment

Product coverage

Adult mouth care; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans; Vitamins and dietary supplements; Wound treatments

Executive summary

OTC medication in demand as Canadian population ages

The ageing trend and longevity among the Canadian population resulted in a rise in health problems associated with ageing, such as proneness to illnesses and injuries. This consequently supported sales of medication and healthcare services. This trend is behind the continuous growth of the OTC medicines industry, however, growth was slower than might be expected. This was due to the impact of alternative health management options, such as prescription drugs, as well as social changes that resulted in a shift towards healthier lifestyles, including better nutrition and more exercise that help to prevent and/or alleviate some ailments.

Strict regulations and greater awareness boost sales of natural healthcare

On the whole, sales of many previously popular vitamins and dietary supplements in Canada continued to decline in 2007, due to weak consumer demand and new strict regulations that led to shrinking product selection at retail. At the same time, strict regulations appear to have led to increased consumer confidence in products found on store shelves as well as to improved information regarding product efficiency and safety. Coupled with a range of recently published studies regarding the benefits of some vitamins and supplements, such as vitamin D, these led to strong growth in retail sales of some natural health care products in 2007.

Acquisitions and advertising further boost leading pharmaceuticals

Brand acquisitions and heavy investment in advertising to support core brands were the main strategies to boost and maintain share of sales in the largely fragmented Canadian OTC industry. In 2006, McNeil Consumer Healthcare became the leading player in Canada, due to the acquisition of many strong OTC brands from Pfizer. Its greatly expanded portfolio of products helped the company to level off weak sales of some medications and it remained the leading player in 2007. In addition, aggressive and innovative advertising by leading marketers of OTC drugs, such as Wyeth for example, contributed to rising sales of their brands, ahead of the competition.

Drugstores remain strong and lead the distribution of OTC

Drugstores remain the leading distribution channel of OTC medications in Canada. This position stems from the fact that many Canadians seek pharmacists’ advice on the use and side effects of medications, as well as to the regulations set by Health Canada that require the distribution of many drugs solely through pharmacies. Retailers’ efforts to expand services and product lines, including those that are non-health related (beauty care first and foremost) are also encouraging more purchases at drugstores.

Overall slow growth is projected

On the whole, retail sales of OTC medications in Canada will witness slow growth in constant value terms. This will largely be due to the anticipated further decline in sales of some previously popular natural health care products. It will also stem from slower sales of some OTC drugs that showed a much stronger rise due to novelty and a switch to OTC status over the review period. Furthermore, the OTC market in Canada is likely to feel the impact of alternative health management strategies, such as prescription drugs as well as social changes towards healthier lifestyles that will ultimately help to address minor ailments treated with OTC drugs.

Table of contents

OTC HEALTHCARE IN CANADA : MARKET INSIGHT

EXECUTIVE SUMMARY

OTC medication in demand as Canadian population ages

Strict regulations and greater awareness boost sales of natural healthcare

Acquisitions and advertising further boost leading pharmaceuticals

Drugstores remain strong and lead the distribution of OTC

Overall slow growth is projected

KEY TRENDS AND DEVELOPMENTS

Ageing Canadians provide expanding consumer base for medications

Natural remedies still appeal although some Canadians are more cautious

Alternative health management options slow sales of OTC medication

Multiple strategies by pharmaceuticals drive sales and industry share

Drugstores still going strong

MARKET INDICATORS

Table 1 Consumer Expenditure on Health Goods and Medical Services 2002-2007

Table 2 Life Expectancy at Birth 2002-2007

MARKET DATA

Table 3 Sales of OTC Healthcare by Sector: Value 2002-2007

Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2002-2007

Table 5 OTC Healthcare Company Shares by Value 2003-2007

Table 6 OTC Healthcare Brand Shares by Value 2004-2007

Table 7 Penetration of Private Label by Sector 2003-2007

Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2002-2007

Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2007

Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2007-2012

Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2007-2012

APPENDIX

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Generics

Switches

Summary 1 OTC Healthcare Switches 2005-2007

DEFINITIONS

Sources

Summary 2 Research Sources

LOCAL COMPANY PROFILES - CANADA

APOTEX INC - OTC HEALTHCARE - CANADA

STRATEGIC DIRECTION

KEY FACTS

Summary 3 Apotex Inc: Key Facts

Summary 4 Apotex Inc: Operational Indicators

COMPANY BACKGROUND

COMPETITIVE POSITIONING

Summary 5 Apotex Inc: Competitive Position 2007

CE JAMIESON & CO LTD - OTC HEALTHCARE - CANADA

STRATEGIC DIRECTION

KEY FACTS

Summary 6 CE Jamieson & Co Ltd: Key Facts

Summary 7 CE Jamieson & Co Ltd: Operational Indicators

COMPANY BACKGROUND

COMPETITIVE POSITIONING

Summary 8 CE Jamieson & Co Ltd: Competitive Position 2007

CV TECHNOLOGIES INC - OTC HEALTHCARE - CANADA

STRATEGIC DIRECTION

KEY FACTS

Summary 9 CV Technologies Inc: Key Facts

Summary 10 CV Technologies Inc: Operational Indicators

COMPANY BACKGROUND

COMPETITIVE POSITIONING

Summary 11 CV Technologies Inc: Competitive Position 2007

PHARMASCIENCE INC - OTC HEALTHCARE - CANADA

STRATEGIC DIRECTION

KEY FACTS

Summary 12 Pharmascience Inc: Key Facts

Summary 13 Pharmascience Inc: Operational Indicators

COMPANY BACKGROUND

COMPETITIVE POSITIONING

Summary 14 Pharmascience Inc: Competitive Position 2007

SWISS HERBAL REMEDIES LTD - OTC HEALTHCARE - CANADA

STRATEGIC DIRECTION

KEY FACTS

Summary 15 Swiss Herbal Remedies Ltd: Key Facts

Summary 16 Swiss Herbal Remedies Ltd: Operational Indicators

COMPANY BACKGROUND

COMPETITIVE POSITIONING

Summary 17 Swiss Herbal Remedies Ltd: Competitive Position 2007

ANALGESICS IN CANADA

HEADLINES

TRENDS

SWITCHES

COMPETITIVE LANDSCAPE

PROSPECTS

SECTOR DATA

Table 12 Sales of Analgesics by Subsector: Value 2002-2007

Table 13 Sales of Analgesics by Subsector: % Value Growth 2002-2007

Table 14 Herbal vs Standard Topical Analgesics 2002-2007

Table 15 Topical Analgesics by Format: % Value Breakdown 2004-2007

Table 16 Analgesics Company Shares by Value 2003-2007

Table 17 Analgesics Brand Shares by Value 2004-2007

Table 18 Forecast Sales of Analgesics by Subsector: Value 2007-2012

Table 19 Forecast Sales of Analgesics by Subsector: % Value Growth 2007-2012

COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN CANADA

HEADLINES

TRENDS

SWITCHES

COMPETITIVE LANDSCAPE

PROSPECTS

SECTOR DATA

Table 20 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2002-2007

Table 21 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2002-2007

Table 22 Sales of Decongestants by Type: Value 2002-2007

Table 23 Sales of Decongestants by Type: % Value Growth 2002-2007

Table 24 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2002-2007

Table 25 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2002-2007

Table 26 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2002-2007

Table 27 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2003-2007

Table 28 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2004-2007

Table 29 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2007-2012

Table 30 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2007-2012

DIGESTIVE REMEDIES IN CANADA

HEADLINES

TRENDS

SWITCHES

COMPETITIVE LANDSCAPE

PROSPECTS

SECTOR DATA

Table 31 Sales of Digestive Remedies by Subsector: Value 2002-2007

Table 32 Sales of Digestive Remedies by Subsector: % Value Growth 2002-2007

Table 33 Herbal vs Standard Digestive Remedies 2002-2007

Table 34 Digestive Remedies Company Shares by Value 2003-2007

Table 35 Digestive Remedies Brand Shares by Value 2004-2007

Table 36 Forecast Sales of Digestive Remedies by Subsector: Value 2007-2012

Table 37 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2007-2012

MEDICATED SKIN CARE IN CANADA

HEADLINES

TRENDS

SWITCHES

COMPETITIVE LANDSCAPE

PROSPECTS

SECTOR DATA

Table 38 Sales of Medicated Skin Care by Subsector: Value 2002-2007

Table 39 Sales of Medicated Skin Care by Subsector: % Value Growth 2002-2007

Table 40 Herbal vs Standard Medicated Skin Care 2002-2007

Table 41 Medicated Skin Care Company Shares by Value 2003-2007

Table 42 Medicated Skin Care Brand Shares by Value 2004-2007

Table 43 Acne Treatments Brand Shares by Value 2004-2007

Table 44 Hair Loss Treatments Brand Shares by Value 2004-2007

Table 45 Forecast Sales of Medicated Skin Care by Subsector: Value 2007-2012

Table 46 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2007-2012

VITAMINS AND DIETARY SUPPLEMENTS IN CANADA

HEADLINES

TRENDS

COMPETITIVE LANDSCAPE

PROSPECTS

SECTOR DATA

Table 47 Sales of Vitamins and Dietary Supplements by Subsector: Value 2002-2007

Table 48 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2002-2007

Table 49 Sales of Vitamins by Type: Value 2002-2007

Table 50 Sales of Vitamins by Type: % Value Growth 2002-2007

Table 51 Sales of Dietary Supplements by Type: Value 2002-2007

Table 52 Sales of Dietary Supplements by Type: % Value Growth 2002-2007

Table 53 Folic Acid v Other B Vitamins 2004-2007

Table 54 Dietary Supplements by Positioning 2006-2007

Table 55 Vitamins and Dietary Supplements Company Shares by Value 2003-2007

Table 56 Vitamins and Dietary Supplements Brand Shares by Value 2004-2007

Table 57 Vitamins Brand Shares by Value 2004-2007

Table 58 Dietary Supplements Brand Shares by Value 2004-2007

Table 59 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2007-2012

Table 60 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2007-2012

NRT SMOKING CESSATION AIDS IN CANADA

HEADLINES

TRENDS

SWITCHES

COMPETITIVE LANDSCAPE

PROSPECTS

SECTOR INDICATORS

Table 61 Number of Smokers by Gender 2002-2007

Table 62 Sales of Smoking Cessation Aids by Subsector: Value 2002-2007

Table 63 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2002-2007

Table 64 NRT Gum Flavours 2006-2007

Table 65 Smoking Cessation Aids Company Shares by Value 2003-2007

Table 66 Smoking Cessation Aids Brand Shares by Value 2004-2007

Table 67 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2007-2012

Table 68 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2007-2012

EYE CARE IN CANADA

OVERVIEW

SECTOR DATA

Table 69 Sales of Eye Care by Subsector: Value 2002-2007

Table 70 Sales of Eye Care by Subsector: % Value Growth 2002-2007

Table 71 Eye Care Company Shares by Value 2003-2007

Table 72 Eye Care Brand Shares by Value 2004-2007

Table 73 Forecast Sales of Eye Care by Subsector: Value 2007-2012

Table 74 Forecast Sales of Eye Care by Subsector: % Value Growth 2007-2012

EAR CARE IN CANADA

OVERVIEW

SECTOR DATA

Table 75 Sales of Ear Care: Value 2002-2007

Table 76 Sales of Ear Care: % Value Growth 2002-2007

Table 77 Ear Care Company Shares by Value 2003-2007

Table 78 Ear Care Brand Shares by Value 2004-2007

Table 79 Forecast Sales of Ear Care: Value 2007-2012

Table 80 Forecast Sales of Ear Care: % Value Growth 2007-2012

ADULT MOUTH CARE IN CANADA

OVERVIEW

SECTOR DATA

Table 81 Sales of Adult Mouth Care: Value 2002-2007

Table 82 Sales of Adult Mouth Care: % Value Growth 2002-2007

Table 83 Adult Mouth Care Company Shares by Value 2003-2007

Table 84 Adult Mouth Care Brand Shares by Value 2004-2007

Table 85 Forecast Sales of Adult Mouth Care: Value 2007-2012

Table 86 Forecast Sales of Adult Mouth Care: % Value Growth 2007-2012

CALMING AND SLEEPING PRODUCTS IN CANADA

OVERVIEW

SECTOR DATA

Table 87 Sales of Calming and Sleeping Products: Value 2002-2007

Table 88 Sales of Calming and Sleeping Products: % Value Growth 2002-2007

Table 89 Calming and Sleeping Products Company Shares by Value 2003-2007

Table 90 Calming and Sleeping Products Brand Shares by Value 2004-2007

Table 91 Forecast Sales of Calming and Sleeping Products: Value 2007-2012

Table 92 Forecast Sales of Calming and Sleeping Products: % Value Growth 2007-2012

WOUND TREATMENTS IN CANADA

OVERVIEW

SECTOR DATA

Table 93 Sales of Wound Treatments by Subsector: Value 2002-2007

Table 94 Sales of Wound Treatments by Subsector: % Value Growth 2002-2007

Table 95 Wound Treatments Company Shares by Value 2003-2007

Table 96 Wound Treatments Brand Shares by Value 2004-2007

Table 97 Forecast Sales of Wound Treatments by Subsector: Value 2007-2012

Table 98 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2007-2012

EMERGENCY CONTRACEPTION IN CANADA

OVERVIEW

SECTOR DATA

Table 99 Sales of Emergency Contraception by Subsector: Value 2002-2007

Table 100 Sales of Emergency Contraception by Subsector: % Value Growth 2002-2007

Table 101 Forecast Sales of Emergency Contraception by Subsector: Value 2007-2012

Table 102 Forecast Sales of Emergency Contraception by Subsector: % Value Growth 2007-2012